Author: Zacks Small Cap Research

1 33 34 35343 / 343 POSTS
By David Bautz, PhDNASDAQ:BCLIBusiness UpdatePhase 3 Trial UnderwayOn October 16, 2017, BrainStorm (NASDAQ:BCLI) announced that the first patients have been enrolled in the Phase 3 clinical trial of NurOwn® (NCT03280056) for the treatment of amyotro ...
By David Bautz, PhDNASDAQ:OPNTBusiness UpdateOpiant Pharmaceuticals, Inc. (NASDAQ:OPNT) is a specialty pharmaceutical company developing treatments for substance use, eating disorders, and addiction disorders based on the company’s expertise in opioi ...
By David Bautz, PhDNASDAQ:AGRXAgile Therapeutics, Inc. (NASDAQ:AGRX) is a women’s healthcare company focused on developing healthcare products to fulfill the unmet contraceptive needs of women. The company’s lead candidate product, Twirla® (AG200-15) ...
1 33 34 35343 / 343 POSTS